05/13/2024
6:30 AM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Quince Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:10 PM | Quince Therapeutics (Filer)
| Form ARS | |
04/11/2024
3:39 PM | Quince Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
4:21 PM | Quince Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/01/2024
3:50 PM | Quince Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
5:09 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
02/15/2024
5:14 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
8:00 AM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SC 13G | |
02/07/2024
9:50 AM | BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
5:02 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:50 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:53 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:00 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
3:48 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:08 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
5:21 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:30 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
12:38 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
4:54 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:42 PM | Janhofer Guenter (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:43 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2023
6:46 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:34 PM | Janhofer Guenter (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
3:05 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
4:40 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
4:43 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:18 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
5:42 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
5:08 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
5:18 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
5:21 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
5:23 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
6:16 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
10:07 AM | BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
| Form SC 13G | |
05/26/2023
4:45 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:47 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:49 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:50 PM | Quince Therapeutics (Issuer)
RYAN UNA S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:53 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
3:23 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
